Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 298

1.

The iNADequacy of renal cell metabolism: modulating NAD+ biosynthetic pathways to forestall kidney diseases.

Perico L, Benigni A.

Kidney Int. 2019 Aug;96(2):264-267. doi: 10.1016/j.kint.2019.03.012. No abstract available.

PMID:
31331461
2.

Addition of cyclic angiotensin-(1-7) to angiotensin-converting enzyme inhibitor therapy has a positive add-on effect in experimental diabetic nephropathy.

Cassis P, Locatelli M, Corna D, Villa S, Rottoli D, Cerullo D, Abbate M, Remuzzi G, Benigni A, Zoja C.

Kidney Int. 2019 May 10. pii: S0085-2538(19)30486-7. doi: 10.1016/j.kint.2019.04.024. [Epub ahead of print]

PMID:
31307778
3.

Sirt3 Deficiency Shortens Life Span and Impairs Cardiac Mitochondrial Function Rescued by Opa1 Gene Transfer.

Benigni A, Cassis P, Conti S, Perico L, Corna D, Cerullo D, Zentilin L, Zoja C, Perna A, Lionetti V, Giacca M, Trionfini P, Tomasoni S, Remuzzi G.

Antioxid Redox Signal. 2019 Aug 2. doi: 10.1089/ars.2018.7703. [Epub ahead of print]

PMID:
31269804
4.

Engineering the vasculature of decellularized rat kidney scaffolds using human induced pluripotent stem cell-derived endothelial cells.

Ciampi O, Bonandrini B, Derosas M, Conti S, Rizzo P, Benedetti V, Figliuzzi M, Remuzzi A, Benigni A, Remuzzi G, Tomasoni S.

Sci Rep. 2019 May 29;9(1):8001. doi: 10.1038/s41598-019-44393-y.

5.

Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS.

Valoti E, Alberti M, Iatropoulos P, Piras R, Mele C, Breno M, Cremaschi A, Bresin E, Donadelli R, Alizzi S, Amoroso A, Benigni A, Remuzzi G, Noris M.

Front Immunol. 2019 May 1;10:853. doi: 10.3389/fimmu.2019.00853. eCollection 2019.

6.

CRISPR-Cas9-Mediated Correction of the G189R-PAX2 Mutation in Induced Pluripotent Stem Cells from a Patient with Focal Segmental Glomerulosclerosis.

Trionfini P, Ciampi O, Todeschini M, Ascanelli C, Longaretti L, Perico L, Remuzzi G, Benigni A, Tomasoni S.

CRISPR J. 2019 Apr;2:108-120. doi: 10.1089/crispr.2018.0048.

PMID:
30998089
7.

Ultrasound Evaluation of Diaphragmatic Mobility and Contractility After Osteopathic Manipulative Techniques in Healthy Volunteers: A Prospective, Randomized, Double-Blinded Clinical Trial.

Mancini D, Cesari M, Lunghi C, Benigni AM, Antonelli Incalzi R, Scarlata S.

J Manipulative Physiol Ther. 2019 Jan;42(1):47-54. doi: 10.1016/j.jmpt.2018.08.001. Epub 2019 Apr 5.

PMID:
30955907
8.

Hemolytic Uremic Syndrome in an Infant with Primary Hyperoxaluria Type II: An Unreported Clinical Association.

Valoti E, Alberti M, Carrara C, Breno M, Yilmaz Keskin E, Bresin E, Cuccarolo P, Açikgöz Y, Benigni A, Noris M, Remuzzi G, Mele C.

Nephron. 2019;142(3):264-270. doi: 10.1159/000497823. Epub 2019 Mar 19.

PMID:
30889567
9.

An Ex Vivo Test of Complement Activation on Endothelium for Individualized Eculizumab Therapy in Hemolytic Uremic Syndrome.

Galbusera M, Noris M, Gastoldi S, Bresin E, Mele C, Breno M, Cuccarolo P, Alberti M, Valoti E, Piras R, Donadelli R, Vivarelli M, Murer L, Pecoraro C, Ferrari E, Perna A, Benigni A, Portalupi V, Remuzzi G.

Am J Kidney Dis. 2019 Jul;74(1):56-72. doi: 10.1053/j.ajkd.2018.11.012. Epub 2019 Mar 7.

PMID:
30851964
10.

The incessant search for renal biomarkers: is it really justified?

Perico L, Perico N, Benigni A.

Curr Opin Nephrol Hypertens. 2019 Mar;28(2):195-202. doi: 10.1097/MNH.0000000000000481.

PMID:
30531471
11.

Unraveling the Molecular Mechanisms Underlying Complement Dysregulation by Nephritic Factors in C3G and IC-MPGN.

Donadelli R, Pulieri P, Piras R, Iatropoulos P, Valoti E, Benigni A, Remuzzi G, Noris M.

Front Immunol. 2018 Oct 15;9:2329. doi: 10.3389/fimmu.2018.02329. eCollection 2018.

12.
13.

A new BEACON of hope for the treatment of inflammation? The endogenous metabolite itaconate as an alternative activator of the KEAP1-Nrf2 system.

Perico L, Wyatt CM, Benigni A.

Kidney Int. 2018 Oct;94(4):646-649. doi: 10.1016/j.kint.2018.07.018. No abstract available.

PMID:
30243306
14.

Reproducibility and Clinical Correlates of Supine Diaphragmatic Motion Measured by M-Mode Ultrasonography in Healthy Volunteers.

Scarlata S, Mancini D, Laudisio A, Benigni A, Antonelli Incalzi R.

Respiration. 2018;96(3):259-266. doi: 10.1159/000489229. Epub 2018 Aug 16.

PMID:
30114702
15.

Therapeutic potential of stromal cells of non-renal or renal origin in experimental chronic kidney disease.

Rota C, Morigi M, Cerullo D, Introna M, Colpani O, Corna D, Capelli C, Rabelink TJ, Leuning DG, Rottoli D, Benigni A, Zoja C, Remuzzi G.

Stem Cell Res Ther. 2018 Aug 14;9(1):220. doi: 10.1186/s13287-018-0960-8.

16.

SGLT2 inhibitor dapagliflozin limits podocyte damage in proteinuric nondiabetic nephropathy.

Cassis P, Locatelli M, Cerullo D, Corna D, Buelli S, Zanchi C, Villa S, Morigi M, Remuzzi G, Benigni A, Zoja C.

JCI Insight. 2018 Aug 9;3(15). pii: 98720. doi: 10.1172/jci.insight.98720. eCollection 2018 Aug 9.

17.

Engineered Kidney Tubules for Modeling Patient-Specific Diseases and Drug Discovery.

Benedetti V, Brizi V, Guida P, Tomasoni S, Ciampi O, Angeli E, Valbusa U, Benigni A, Remuzzi G, Xinaris C.

EBioMedicine. 2018 Jul;33:253-268. doi: 10.1016/j.ebiom.2018.06.005. Epub 2018 Jul 3.

18.

ADAMTS13 Deficiency Shortens the Life Span of Mice With Experimental Diabetes.

Cassis P, Cerullo D, Zanchi C, Corna D, Lionetti V, Giordano F, Novelli R, Conti S, Casieri V, Matteucci M, Locatelli M, Taraboletti G, Villa S, Gastoldi S, Remuzzi G, Benigni A, Zoja C.

Diabetes. 2018 Oct;67(10):2069-2083. doi: 10.2337/db17-1508. Epub 2018 Jul 5.

19.

The role of B7-1 in proteinuria of glomerular origin.

Novelli R, Benigni A, Remuzzi G.

Nat Rev Nephrol. 2018 Sep;14(9):589-596. doi: 10.1038/s41581-018-0037-z. Review.

PMID:
29959373
20.

Sirtuins in Renal Health and Disease.

Morigi M, Perico L, Benigni A.

J Am Soc Nephrol. 2018 Jul;29(7):1799-1809. doi: 10.1681/ASN.2017111218. Epub 2018 Apr 30. Review.

21.

Early and late scanning electron microscopy findings in diabetic kidney disease.

Conti S, Perico N, Novelli R, Carrara C, Benigni A, Remuzzi G.

Sci Rep. 2018 Mar 20;8(1):4909. doi: 10.1038/s41598-018-23244-2.

22.

Human mesenchymal stromal cells transplanted into mice stimulate renal tubular cells and enhance mitochondrial function.

Perico L, Morigi M, Rota C, Breno M, Mele C, Noris M, Introna M, Capelli C, Longaretti L, Rottoli D, Conti S, Corna D, Remuzzi G, Benigni A.

Nat Commun. 2017 Oct 17;8(1):983. doi: 10.1038/s41467-017-00937-2.

23.

Extracellular vesicles derived from T regulatory cells suppress T cell proliferation and prolong allograft survival.

Aiello S, Rocchetta F, Longaretti L, Faravelli S, Todeschini M, Cassis L, Pezzuto F, Tomasoni S, Azzollini N, Mister M, Mele C, Conti S, Breno M, Remuzzi G, Noris M, Benigni A.

Sci Rep. 2017 Sep 14;7(1):11518. doi: 10.1038/s41598-017-08617-3.

24.

The Role of Angiotensin II in Parietal Epithelial Cell Proliferation and Crescent Formation in Glomerular Diseases.

Rizzo P, Novelli R, Rota C, Gagliardini E, Ruggiero B, Rottoli D, Benigni A, Remuzzi G.

Am J Pathol. 2017 Nov;187(11):2441-2450. doi: 10.1016/j.ajpath.2017.07.004. Epub 2017 Aug 12.

PMID:
28807596
25.

MicroRNA-184 is a downstream effector of albuminuria driving renal fibrosis in rats with diabetic nephropathy.

Zanchi C, Macconi D, Trionfini P, Tomasoni S, Rottoli D, Locatelli M, Rudnicki M, Vandesompele J, Mestdagh P, Remuzzi G, Benigni A, Zoja C.

Diabetologia. 2017 Jun;60(6):1114-1125. doi: 10.1007/s00125-017-4248-9. Epub 2017 Mar 31.

26.

AAV9-mediated engineering of autotransplanted kidney of non-human primates.

Tomasoni S, Trionfini P, Azzollini N, Zentilin L, Giacca M, Aiello S, Longaretti L, Cozzi E, Baldan N, Remuzzi G, Benigni A.

Gene Ther. 2017 May;24(5):308-313. doi: 10.1038/gt.2017.21. Epub 2017 Mar 27.

PMID:
28346435
27.

Complement Alternative Pathway Deficiency in Recipients Protects Kidney Allograft From Ischemia/Reperfusion Injury and Alloreactive T Cell Response.

Casiraghi F, Azzollini N, Todeschini M, Fiori S, Cavinato RA, Cassis P, Solini S, Pezzuto F, Mister M, Thurman JM, Benigni A, Remuzzi G, Noris M.

Am J Transplant. 2017 Sep;17(9):2312-2325. doi: 10.1111/ajt.14262. Epub 2017 Apr 10.

28.

Experimental Evaluation of Kidney Regeneration by Organ Scaffold Recellularization.

Remuzzi A, Figliuzzi M, Bonandrini B, Silvani S, Azzollini N, Nossa R, Benigni A, Remuzzi G.

Sci Rep. 2017 Mar 7;7:43502. doi: 10.1038/srep43502.

29.

BRAF Signaling Pathway Inhibition, Podocyte Injury, and Nephrotic Syndrome.

Perico L, Mandalà M, Schieppati A, Carrara C, Rizzo P, Conti S, Longaretti L, Benigni A, Remuzzi G.

Am J Kidney Dis. 2017 Jul;70(1):145-150. doi: 10.1053/j.ajkd.2016.12.013. Epub 2017 Feb 24.

PMID:
28242136
30.

MicroRNAs as Master Regulators of Glomerular Function in Health and Disease.

Trionfini P, Benigni A.

J Am Soc Nephrol. 2017 Jun;28(6):1686-1696. doi: 10.1681/ASN.2016101117. Epub 2017 Feb 23. Review.

31.

Local gene therapy with indoleamine 2,3-dioxygenase protects against development of transplant vasculopathy in chronic kidney transplant dysfunction.

Vavrincova-Yaghi D, Deelman LE, van Goor H, Seelen MA, Vavrinec P, Kema IP, Gomolcak P, Benigni A, Henning RH, Sandovici M.

Gene Ther. 2016 Nov;23(11):820. doi: 10.1038/gt.2016.68. No abstract available.

PMID:
27808123
32.

Local gene therapy with indoleamine 2,3-dioxygenase protects against development of transplant vasculopathy in chronic kidney transplant dysfunction.

Vavrincova-Yaghi D, Deelman LE, van Goor H, Seelen MA, Vavrinec P, Kema IP, Gomolcak P, Benigni A, Henning RH, Sandovici M.

Gene Ther. 2016 Nov;23(11):797-806. doi: 10.1038/gt.2016.59. Epub 2016 Jul 25. Erratum in: Gene Ther. 2016 Nov;23 (11):820.

PMID:
27454318
33.

Podocyte-actin dynamics in health and disease.

Perico L, Conti S, Benigni A, Remuzzi G.

Nat Rev Nephrol. 2016 Nov;12(11):692-710. doi: 10.1038/nrneph.2016.127. Epub 2016 Aug 30. Review.

PMID:
27573725
34.

Untangling the Knot in Diabetic Nephropathy: The Unanticipated Role of Glycocalyx in the Antiproteinuric Effect of Endothelin Receptor Antagonists.

Buelli S, Perico L, Benigni A.

Diabetes. 2016 Aug;65(8):2115-7. doi: 10.2337/dbi16-0020. No abstract available.

35.

Mitochondrial Sirtuin 3 and Renal Diseases.

Perico L, Morigi M, Benigni A.

Nephron. 2016;134(1):14-9. doi: 10.1159/000444370. Epub 2016 Jul 1. Review.

36.

A previously unrecognized role of C3a in proteinuric progressive nephropathy.

Morigi M, Locatelli M, Rota C, Buelli S, Corna D, Rizzo P, Abbate M, Conti D, Perico L, Longaretti L, Benigni A, Zoja C, Remuzzi G.

Sci Rep. 2016 Jun 27;6:28445. doi: 10.1038/srep28445.

37.

Generation of functional podocytes from human induced pluripotent stem cells.

Ciampi O, Iacone R, Longaretti L, Benedetti V, Graf M, Magnone MC, Patsch C, Xinaris C, Remuzzi G, Benigni A, Tomasoni S.

Stem Cell Res. 2016 Jul;17(1):130-9. doi: 10.1016/j.scr.2016.06.001. Epub 2016 Jun 3.

38.

Another Piece of the Puzzle of Podocyte B7-1 Expression: Lupus Nephritis.

Novelli R, Gagliardini E, Ruggiero B, Benigni A, Remuzzi G.

Nephron. 2016;133(2):129-38. doi: 10.1159/000446324. Epub 2016 May 21.

PMID:
27198457
39.

Inhibiting angiotensin-converting enzyme promotes renal repair by modulating progenitor cell activation.

Rizzo P, Novelli R, Benigni A, Remuzzi G.

Pharmacol Res. 2016 Jun;108:16-22. doi: 10.1016/j.phrs.2016.04.009. Epub 2016 Apr 16. Review.

PMID:
27095084
40.

Mitochondrial Dynamics Is Linked to Longevity and Protects from End-Organ Injury: The Emerging Role of Sirtuin 3.

Benigni A, Perico L, Macconi D.

Antioxid Redox Signal. 2016 Aug 1;25(4):185-99. doi: 10.1089/ars.2016.6682. Epub 2016 Apr 19. Review.

PMID:
26972664
41.

Life and Death of Podocytes: Not Only a Matter of Vascular Endothelial Growth Factor.

Novelli R, Benigni A.

Am J Nephrol. 2016;43(2):71-3. doi: 10.1159/000444723. Epub 2016 Mar 2. No abstract available.

42.

Any value of podocyte B7-1 as a biomarker in human MCD and FSGS?

Novelli R, Gagliardini E, Ruggiero B, Benigni A, Remuzzi G.

Am J Physiol Renal Physiol. 2016 Mar 1;310(5):F335-41. doi: 10.1152/ajprenal.00510.2015. Epub 2015 Dec 23.

43.

Therapy with a Selective Cannabinoid Receptor Type 2 Agonist Limits Albuminuria and Renal Injury in Mice with Type 2 Diabetic Nephropathy.

Zoja C, Locatelli M, Corna D, Villa S, Rottoli D, Nava V, Verde R, Piscitelli F, Di Marzo V, Fingerle J, Adam JM, Rothenhaeusler B, Ottaviani G, Bénardeau A, Abbate M, Remuzzi G, Benigni A.

Nephron. 2016;132(1):59-69. doi: 10.1159/000442679. Epub 2015 Dec 9.

PMID:
26646377
44.

Functional Human Podocytes Generated in Organoids from Amniotic Fluid Stem Cells.

Xinaris C, Benedetti V, Novelli R, Abbate M, Rizzo P, Conti S, Tomasoni S, Corna D, Pozzobon M, Cavallotti D, Yokoo T, Morigi M, Benigni A, Remuzzi G.

J Am Soc Nephrol. 2016 May;27(5):1400-11. doi: 10.1681/ASN.2015030316. Epub 2015 Oct 29.

45.

B7-1 Is Not Induced in Podocytes of Human and Experimental Diabetic Nephropathy.

Gagliardini E, Novelli R, Corna D, Zoja C, Ruggiero B, Benigni A, Remuzzi G.

J Am Soc Nephrol. 2016 Apr;27(4):999-1005. doi: 10.1681/ASN.2015030266. Epub 2015 Aug 28.

46.

Key fibrogenic mediators: old players. Renin-angiotensin system.

Macconi D, Remuzzi G, Benigni A.

Kidney Int Suppl (2011). 2014 Nov;4(1):58-64. Review.

47.

Sirtuin 3 in acute kidney injury.

Perico L, Remuzzi G, Benigni A.

Oncotarget. 2015 Jul 10;6(19):16814-5. No abstract available.

48.

Key pathways in renal disease progression of experimental diabetes.

Zoja C, Zanchi C, Benigni A.

Nephrol Dial Transplant. 2015 Aug;30 Suppl 4:iv54-9. doi: 10.1093/ndt/gfv036. Review.

PMID:
26209738
49.

Time course of cytokines, hemodynamic and metabolic parameters during hyperthermic intraperitoneal chemotherapy.

Coccolini F, Corbella D, Finazzi P, Brambillasca P, Benigni A, Prussiani V, Ceresoli M, Manfredi R, Poiasina E, Bertoli P, Catena F, Bianchetti A, Bontempelli M, Lorini LF, Sonzogni V, Ansaloni L.

Minerva Anestesiol. 2016 Mar;82(3):310-9. Epub 2015 Jul 16.

50.

Time course of cytokines, hemodynamic and metabolic parameters during hyperthermic intraperitoneal chemotherapy.

Coccolini F, Corbella D, Finazzi P, Brambillasca P, Benigni A, Prussiani V, Ceresoli M, Manfredi R, Poiasina E, Bertoli P, Catena F, Bianchetti A, Bontempelli M, Lorini LF, Sonzogni V, Ansaloni L.

Minerva Anestesiol. 2015 Jul 8. [Epub ahead of print]

Supplemental Content

Loading ...
Support Center